Volume 27, Issue 2 pp. 568-571
Short Paper
Full Access

Binding of a soluble p70 killer cell inhibitory receptor to HLA-B*5101: Requirement for all three p70 immunoglobulin domains

Susana Rojo

Susana Rojo

Laboratory of Immunogenetics, National Intitute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, USA

Search for more papers by this author
Nicolai Wagtmann

Nicolai Wagtmann

Laboratory of Immunogenetics, National Intitute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, USA

Search for more papers by this author
Eric O. Long

Corresponding Author

Eric O. Long

Laboratory of Immunogenetics, National Intitute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, USA

LIG-NIAID-NIH Twinbrook II, 12441 Parklawn Drive, Rockville, MD 20852-1727, USA Fax: +1-301-402-0259Search for more papers by this author
First published: 06 December 2005
Citations: 51

Abstract

Lysis of target cells by natural killer (NK) cells can be prevented by killer cell inhibitory receptors (KIR) specific for major histocompatibility complex class I molecules. Functional studies have identified two distinct p58 KIR, each reactive with a different group of HLA-C allotypes, and distinct p70 KIR specific for some HLA-B or HLA-A allotypes. The NK specificities for each group of HLA-C allotypes have been reproduced by direct binding of recombinant soluble p58 molecules. Here, we show that a soluble p70 KIR binds to HLA-B*5101, but not to HLA-A or HLA-C molecules. Truncated soluble forms of the HLA-B*5101-specific p70 KIR, including one with two immunoglobulin (Ig) domains reactive with a monoclonal antibody that blocks p70 KIR function, did not bind to HLA-B*5101, indicating that all three Ig domains are required for binding.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.